Prof. Dr. med. Oliver Reich

Chefarzt der Klinik für Urologie und Chirurgie

München Klinik Harlaching

Kontakt

Tel: (089) 6210-2791

Nachricht an Prof. Dr. med. Oliver Reich

Adresse

München Klinik Harlaching Sanatoriumsplatz 2, 81545 München

  • Personalien >>

06/2008 - heute
Vorstandsmitglied und Schatzmeister der Bayerischen Urologenvereinigung e.V.

01/2008 - 06/2010
Gründer und Leiter des interdisziplinären Prostatazentrum der LMU München

01/2009
Zusatzbezeichnung "Medikamentöse Tumortherapie"

12/2008
Zusatzbezeichnung "Andrologie" (Bayerische Landesärztekammer)

09/2005 - heute
Mitglied und Schriftführer des Arbeitskreis "BPH" der Deutschen Gesellschaft für Urologie

01/2003 - heute
Mitglied "Fachkommission Urologie" der Bayerischen Arbeitsgemeinschaft für Qualitätssicherung in der stationären Versorgung

Berufstätigkeit
seit 2010
 
Chefarzt der Klinik für Urologie am Klinikum Harlaching

01/2007 - 2010 
Stellvertretender Klinikdirektor und Leitender Oberarzt der Urologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München

02/2003 - 12/2006
Oberarzt der Urologischen Klinik der LMU München

12/2001
Facharzt für Urologie

12/1994 - 12/1995
Praktisches Jahr in St. Gallen, Zürich, San Francisco und München

04/1996 - 07/1997
Assistenzarzt an der Urologischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. D. Ackermann)

08/1997 - 07/1998
Assistenzarzt an der Chirurgischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. J. Lange)

08/1998 - 08/1999
Wissenschaftlicher Angestellter an der Urologischen Klinik der Gutenberg-Universität Mainz (Prof. Dr. J. Thüroff)

08/1999 - 01/2003
Wissenschaftlicher Mitarbeiter der Urologischen Klinik der LMU München (Prof. Dr. Dr. hc. mult. A Hofstetter)

Habilitation
10/2004

Experimentelle und klinische Untersuchungen zur Reduzierung des Blutverlustes bei der transurethralen Therapie der benignen Prostatahyperplasie

Studium und Promotion
05/1989 - 11/1995

Studium der Humanmedizin an der LMU München

08/1993 - 11/1993
Research Associate in Harare, Zimbabwe. Prof. Dr. B. Reichart, Klinik für Herzchirurgie, LMU München

10/1998
In-vitro-Untersuchungen zur Elektro-Vaporisation der Prostata

Sein medizinischer Schwerpunkt liegt in der minimalinvasiven, funktionserhaltenden operativen Therapie von Erkrankungen der Prostata, der Harnblase sowie des oberen Harntraktes (Nieren wie Harnleiter). 
Besonders auf dem Gebiet der Prostataerkrankungen gilt er als ausgewiesener Experte: Prof. Reich führte 2003 deutschlandweit die erste „Greenlight“-Laser-Behandlung der Prostata durch und gilt national und international als Referenzoperateur für dieses Verfahren.

Ein weiterer medizinischer Schwerpunkt ist die funktionserhaltende offen-chirurgische Therapie onko-urologischer Erkrankungen. Dies betrifft sowohl die nerv- und gefäßschonende radikale Prostataentfernung als auch die partielle Nephrektomie unter Schonung des gesunden, nicht tumortragenden Nierengewebes. 
Ein zusätzlicher Fokus liegt auf der Bildung einer sogenannten Neoblase aus Darmsegmenten im Falle einer radikalen Zystektomie, also einer kompletten Harnblasenentfernung.

Buchbeiträge, reviews, comments (pubmed indexed)

  • Reich O, Muschter R
    Lasertherapy of BPH. In: Laser Procedures in Urology. Edit.: A. Hofstetter.
    Georg Thieme Verlag; Stuttgart, New York, 2003; p. 54-64
  • Seitz M, Reich O, Stief CG
    Hodentumore.  In: Springer Lexikon Diagnose & Therapie. Edit.: P. Reuter. 
    Springer Medizin Verlag; Heidelberg, 2006; p. 651-660
  • Reich O, Stief CG
    Verletzungen des Urogenitalsystems. In: Praxis der Orthopädie und Unfallchirurgie. Edit.: Wirth / Mutschler. 
    Georg Thieme Verlag; Stuttgart, New York, 2007; p. 418-427
  • Reich O, Stief CG
    Verletzungen des Urogenitalsystems. In: Facharztprüfung Orthopädie und Unfallchirurgie. Edit.: Wirth / Mutschler. 
    Georg Thieme Verlag; Stuttgart, New York, 2007
  • Reich O, Oberneder R, Knüchel R, Naujoks K, Stepp H, Weber W, Gerl A, Michaelis U, Sauer B, Hofstetter A
    Tumor detection by neo-vascular targeting with cationic liposomes 
    Proceedings of the American Society for Clinical Oncology; 22:218, 2003
  • Knüchel R, Bartelheim K, Reich O, Oberneder R, Stepp H, Michaelis U, Naujoks K, Sauer B
    Cationic liposomes for tumor imaging: First clinical results
    Proceedings of the American Association for Cancer Research; 44 (2nd edition), 2003
  • Reich O, Ackermann D
    Reconstructive surgery of the upper urinary tract - did the minimally invasive techniques evolve to new standard treatments ?  
    Current Opinion in Urology; 7(3): 133-37, 1997 (IF 2,619)
  • Reich O, Faul P
    Aktuelle Therapie des Prostatacarcinoms
    Zeitschrift für Ärztliche Fortbildung und Qualitätssicherung; 92(5): 311-18, 1998
  • Hausmann R, Thalmann G, Reich O, Stief CG
    Therapy of benign prostatic hyperplasia with finasteride and doxazosin - long-term studies support the combination. 
    Aktuelle Urologie; 35(5): 339-342, 2004 (IF 0,168)
  • Zaak D, Karl A, Knüchel R, Stepp H, Hartmann A, Reich O, Bachmann A, Siebels M, Popken G, Stief C
    Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    British Journal of Urology International; 96(2): 217-222, 2005 (IF 2,704)
  • Gratzke C, Becker AJ, Park JW, Reich O, Waldkirch E, Schlenker B, Stief CG
    Management of erectile dysfunction in the cardiac patient
    Dtsch Med Wochenschr 16; 130(50): 2899-2903, 2005 (IF 0,625)
  • Gratzke C, Reich O, Bachmann A, Seitz M, Stief CG
    Acute urinary retention in the benign prostatic syndrome
    MMW Fortschr Med 13; 147(41): 45, 2005
  • Seitz M, Scher B, Graser A, Reich O, Gratzke C, Scher M, Stief C, Muller-Lise UG
    Advances in metabolic imaging in patients with elevated prostate specific antigen (PSA)
    European Urology Update Series; 4: 20-32, 2006
  • Reich O, Gratzke C, Stief CG
    Techniques and long term results of surgical procedures for BPH 
    European Urology; 49(6): 970-978, 2006 (IF 6,512)
  • Reich O, Seitz M, Gratzke C, Schlenker B, Stief CG
    Benigne Prostatic Syndrome (BPS) – Ablative treatments.
    Urologe A; 45(6): 769-782, 2006 (IF 0,391)
  • Gratzke C, Seitz M, Zaak D, Reich O, Schlenker B, Stief CG
    Painless enlargement of the scrotum
    MMW Fortschr Med; 148(26): 42-43, 2006
  • Gratzke C, Reich O, Staehler M, Seitz M, Schlenker B, Stief CG
    Risk assessment and medical management of acute urinary retention in patients with benign prostatic syndrome
    EAU-EBU Update Series; 4(3): 109-116, 2006
  • Seitz M, Schlenker B, Gratzke C, Weidlich P, Stief CG, Reich O
    Standards for the punch biopsy of the prostate
    MMW Fortschr Med; 149(4): 35-36, 2007
  • Seitz M, Scher B, Scherr M, Tilki D, Schlenker B, Gratzke C, Schipf A, Stanislaus P, Muller-Lise UG, Reich O, Stief C 
    Imaging procedures to diagnose prostate cancer
    Urologe A; 46(10): 1435-1446, 2007 (IF 0,391)
  • Reich O
    Editorial comment on: A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system
    European Urology; 52(2): 523-524, 2007 (IF 6,512)
  • Gratzke C, Reich O
    Editorial comment on: Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine and prostate volume
    European Urology; 52(3): 835, 2007 (IF 6,512)
  • Gratzke C, Reich O
    Editorial comment on: Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate and possible impact of the learning curve
    European Urology; 52(5): 1471-1472, 2007 (IF 6,512)
  • Seitz M, Gratzke C, Schlenker K, Stanislaus P, Walther S, Reich O, Stief CG
    Benign prostatic hyperplasia: Surgical treatment 
    MMW Fortschr Med 16; 149(33-34): 34-36, 2007
  • Schlenker K, Gratzke C, Weidlich P, Seitz M, Reich O, Stief CG
    Benign prostatic hyperplasia: Medical therapy
    MMW Fortschr Med 16; 149(33-34): 29-31, 2007
  • Gratzke C, Schlenker K, Weidlich P, Seitz M, Reich O, Stief CG
    Benign prostatic hyperplasia: Background and diagnosis
    MMW Fortschr Med 16; 149(33-34): 25-28, 2007
  • Reich O
    Editorial comment on: Transurethral photoselective vaporization of the prostate versus open enucleation for prostatic adenomas > 80 ml: 12 months results of a randomized prospective study
    European Urology; 54(2): 436-437, 2008 (IF 6,512)
  • Reich O
    Editorial comment on: Functional outcome following photoselective vaporization of the prostate (PVP): Urodynamic findings within 12 months follow-up
    European Urology; 54(4): 908, 2008 (IF 6,512)
  • Schlenker B, Gratzke C, Tilki D, Hungerhuber E, Schneede P, Reich O, Stief CG, Seitz M
    Organ-sparing surgery for penile cancer
    Urologe A; 47(7):803-808, 2008 (IF 0,391)
  • Gratzke C, Reich O
    Editorial Comment on: Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature.
    European Urology; 54(4): 776-777, 2008 (IF 6,512)
  • Reich O, Seitz M
    Laservaporisation der Prostata: Alles im grünen Bereich? 
    Urologe A; 47(4): 461-462, 2008 (IF 0,391)
  • Muschter R, Reich O
    Operative und instrumentelle Therapie bei BPH/BPS
    Urologe A; 47(2): 155-165, 2008 (IF 0,391)
  • Faul P, Schlenker B, Gratzke C, Stief CG, Reich O, Hahn R
    Clinical and technical aspects of bipolar transurethral prostate resection.
    Scand J Urol Nephrol; 11: 1-6, 2008 (IF 0,909)
  • Bader MJ, Sroka R, Gratzke C, Seitz M, Weidlich P, Staehler M, Becker A, Stief CG, Reich O
    Laser Therapy for Upper Urinary Tract Transitional Cell Carcinoma: Indications and Management
    European Urology; 2008 Dec 17. [Epub ahead of print] (IF 6,512)
  • Tilki D, Seitz M, Singer BB, Irmak S, Stief CG, Reich O, Ergün S
    Molecular Imaging of Tumor Blood Vessels in Prostate Cancer
    Anticancer Res; 29(5): 1823-1830, 2009 (IF 1,390)
  • Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, Reich O, Stief C, Vavassori I
    A Review of the Recent Evidence (2006-2008) for 532-nm Photoselective Laser Vaporisation and Holmium Laser Enucleation of the Prostate
    European Urology; 55(6):1345-57, 2009 (IF 6,512)
  • Bolenz C, Fernández M, Tilki D, Herrmann E, Heinzelbecker J, Ergün S, Ströbel P, Reich O, Michel MS, Trojan L
    Role of lymphangiogenesis in lymphatic tumor spread of urologic cancers
    British Journal of Urology International; 104(5):592-7, 2009 (IF 2,704)
  • Reich O. 
    Bipolar Transurethral Resection of the Prostate: What Did We Learn, and Where Do We Go from Here? 
    European Urology; 2009 Jul 29. [Epub ahead of print] (IF 6,512)
  • Bader MJ, Seitz M, Reich O, Stief CG, Gratzke C.
    Reply to Lina Matera's Letter to the Editor re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser Therapy for Upper Urinary Tract Transitional Cell Carcinoma: Indications and Management. 
    European Urology; 2009 Jul 31. [Epub ahead of print] (IF 6,512).
  • Berges R, Dreikorn K, Höfner K, Madersbacher S, Michel MC, Muschter R, Oelke M, Reich O, Rulf W, Tschuschke C, Tunn U.
    Diagnostic and differential diagnosis of benign prostate syndrome (BPS): Guidelines of the German Urologists 
    Urologe A; 2009 Sep 9. [Epub ahead of print] (IF 0,391)
  • Berges R, Dreikorn K, Höfner K, Madersbacher S, Michel MC, Muschter R, Oelke M, Reich O, Rulf W, Tschuschke C, Tunn U.
    Therapy of benign prostate syndrome (BPS): Guidelines of the German Urologists (DGU). 
    Urologe A; 2009 Sep 9. [Epub ahead of print] (IF 0,391)
  • Schlenker B, Seitz M, Reich O, Stief CG, Gratzke C.
    Diagnostik und Epidemiologie der BPH
    MMW Fortschr Med; 151:30-2, 2009
  • Schlenker B, Beer AM, Gratzke C, Tilki D, Seitz M, Stief CG, Reich O
    Etablierte und neue Wege in der medikamentösen Therapie des benignen Prostatasyndroms
    MMW Fortschr Med; 151:33-6, 2009
  • Schlenker B, Gratzke C, Tilki D, Seitz M, Karl A, Stief CG, Reich O
    Operative Therapie des benignen Prostatasyndroms.
    MMW Fortschr Med; 151:37-9, 2009
  • Bader MJ, Reich O, Stief CG, Gratzke C
    Reply to Joan Palou, Oscar Rodríguez and Alberto Breda's Letter to the Editor re: Markus J. Bader, Ronald Sroka, Christian Gratzke, et al. Laser Therapy for Upper Urinary Tract Transitional Cell Carcinoma: Indications and Management
    European Urology; [Epub ahead of print] (IF 6,512).
  • Rieken M, Bachmann A, Reich O
    Re: High Power Diode Laser Vaporization of the Prostate: Preliminary Results for Benign Prostatic Hyperplasia A. Erol, K. Cam, A. Tekin, O. Memik, S. Coban and Y. Ozer J Urol 2009; 182: 1078-1082
    Journal of Urology; 2009 Dec 18. [Epub ahead of print] (IF 3,952)
  • Reich O, Seitz M, Gratzke C, Schlenker B, Walther S, Stief C
    Benign prostatic hyperplasia (BPH): Surgical therapy options
    Urologe A; 2009 Dec 24. [Epub ahead of print] (IF 0,391)
  • Seitz M, Bader M, Strittmatter F, Gratzke C, Tilki D, Roosen A, Schlenker B, Reich O. Stief CG. 
    Lymphknotenmetastasendiagnostik bei urologischen Tumoren.
    Urologe A; 49(3): 356-63, 2010. German. (IF: 0,391)
  • Bader MJ, Tilki D, Gratzke C, Sroka R, Stief CG, Reich O 
    Ho:YAG-Laser: Treatment of vesicourethral strictures after radical prostatectomy
    World J Urol; 2010 Feb 25. [Epub ahead of print] (IF 2,699)

Originalarbeiten (peer reviewed)

  • Faul P, Farin G, Reich O, Steude U
    The "Band-Electrode": First Experiences with a novel TURP Procedure to improve Hemostasis.
    European Urology; 30(3): 403-408, 1996 (IF 6,512)
  • Faul P, Farin G, Reich O
    Improvement of hemostasis during TUR-P by a modified resection -technique and -electrode (bandloop).
    Urologe; 37: 569-576, 1997 (IF 0,391)
  • Corvin S, Liedl B, Adam C, Zaak D, Reich O, Stürminger P, Hofstetter A
    Simultaneous Microsurgical Spermatic Vein Ligation and Sclerotherapy: A combined procedure for the treatment of recurrent or persistent varicocele.
    European Urology; 40(3): 350-3, 2001 (IF 6,512)
  • Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A
    In-vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP) and vaporization-resection of the prostate (TUVRP)
    Urological Research; 30:15-20, 2002 (IF 1,615)
  • Corvin S, Schneede P, Siakavara E, Frimberger D, Zaak D, Siebels M, Reich O, Hofstetter A
    Interstitial laser coagulation combined with minimal transurethral resection of the prostate for the treatment of benign prostatic hyperplasia.
    Journal of Endourology; 16(6):387-90, 2002 (IF 1,930)
  • Reich O, Schneede P, Zaak D, Siebels M, Hofstetter A 
    Ex-vivo-comparison of the hemostatic properties of transurethral resection of the prostate (TURP) and transurethral vaporization of the prostate (TUVRP)
    British Journal of Urology International; 92(3): 319-22, 2003 (IF 2,704)
  • Reich O, Schneede P, Mseddi A, Zaak D, Siebels M, Hofstetter A 
    Argon Plasma Coagulation for endourological procedures: ex-vivo evaluations of hemostatic properties. 
    European Urology; 44(2): 272-6, 2003 (IF 6,512)
  • Reich O, Schneede P, Corvin S, Zaak D, Sroka R, Hofstetter A 
    Combination of Interstitial Laser Coagulation (ILC) and Transurethral Resection of the Prostate (TURP): Ex-vivo-evaluations
    Urology; 61(6): 1172-76, 2003 (IF 2,242)
  • Reich O, Hungerhuber E, Hofstetter A, Siebels M, Gusbeth G, Schneede P 
    Fluorescence guided laser therapy of urethral warts.
    Medical Laser Application; 18(2): 117-22, 2003
  • Zaak D, Sroka R, Höppner M, Khoder W, Reich O, Tritschler S, Muschter R, Knüchel R, Hofstetter A 
    Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer – preliminary results.
    Medical Laser Application; 18(1): 91-95, 2003
  • Zaak D, Sroka R, Stocker S, Bise K, Lein M, Höppner M, Frimberger D, Schneede P, Reich O, Kriegmair M, Knüchel R, Baumgartner R, Hofstetter A
    Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX – in-vivo experiments on the dunning rat tumor model.
    Urologia Internationalis; 72(3):196-202, 2004 (IF 0,891)
  • Reich O, Faul P
    The band electrode: Ongoing experience with a novel TURP loop to improve hemostasis in 265 patients.
    Urologia Internationalis; 71(1): 40-45, 2004 (IF 0,891)
  • Siebels M, Theodorakis J, Schmeller N, Corvin S, Mistry-Burchardi N, Hillebrand G, Frimberger D, Reich O, Land W, Hofstetter A
    Risks and complications in 160 living kidney donors who underwent nephroureterectomyNephrology Dialysis Transplantation; 18(12): 2648-54, 2003 (IF 3,568)
  • Reich O, Mseddi A, Zaak D, Trottmann M, Hungerhuber E, Schneede P
    The use of argon plasma coagulation (APC) in endourology: In-vitro experiments 
    Urology; 63(2): 387-91, 2004 (IF 2,242)
  • Reich O, Michel MS, Schneede P, Liedl B, Hofstetter A
    Durability of probes for Interstitial Laser Coagulation (ILC): Impact of power setting and probe design
    Journal of Endourology; 18(3): 299-302, 2004 (IF 1,930)
  • Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A
    Experimental comparison of high power (80W) Potassium Titanyl Phosphate (KTP) Laser Vaporization and Transurethral Resection of the Prostate
    Journal of Urology; 171(6): 2502-2504, 2004 (IF 3,952)
  • Bachmann A, Reich O, Wyler S, Ruszat R, Casella R, Gasser T, Sulser T
    The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures. 
    Urologe A; 43(10):1262-1270, 2004 (IF 0,391)
  • Wendt-Nordahl G, Hacker A, Reich O, Djavan B, Alken P, Michel MS
    The Vista System: A New Bipolar Resection Device for Endourological Procedures: Comparison with Conventional Resectoscope. 
    European Urology; 46(5): 586-590, 2004 (IF 6,512)
  • Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann 
    A Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. Journal of Endourology; 18(10): 976-981, 2004 (IF 1,930)
  • Reich O, Bachmann A, Siebels M, Hofstetter A, Stief C, Sulser T
    High Power (80W) Potassium-Titanyl-Phosphate (KTP) Laser Vaporization Of The Prostate In 66 High Risk Patients.
    Journal of Urology; 173(1): 158-160, 2005 (IF 3,952)
  • Bachmann A, Sulser T, Jayet C, Wyler S, Ruszat R, Reich O, Gasser TC, Siebels M, Stief CG, Casella R
    Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5mm ultrathin cryoprobes: a preliminary report.
    European Urology; 47(4): 474-479, 2005 (IF 6,512)
  • Bachmann A, Giannini O, Wolff T, Dickenmann M, Ruszat R, Langer I, Gurke L, Gasser TC, Reich O, Stief CG, Steiger J, Sulser T
    Retroperitoneoscopic living donor nephrectomy: a comparison with the open approach in respect of early postoperative pain management.
    Transplant Proc; 37(2): 609-612, 2005 (IF 1,055)
  • Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T.
    Photoselective vaporization of the prostate: the Basel experience after 108 procedures.
    European Urology; 47(6): 798-804, 2005 (IF 6,512)
  • Wendt-Nordahl G, Hacker A, Fastenmeier K, Knoll T, Reich O, Alken P, Michel MS
    New Bipolar Resection Device for Transurethral Resection of the Prostate: First ex-Vivo and in-Vivo Evaluation
    Journal of Endourology; 19(10): 1203-1209, 2005 (IF 1,930)
  • Reich O, Noll M, Gratzke C, Bachmann A, Waidelich R, Seitz M, Schlenker B, Baumgartner R, Hofstetter A,  Stief CG
    A high-level virtual reality simulator for endourological procedures of the lower urinary tract
    Urology; 67(6): 1144-1448, 2006 (IF 2,242)
  • Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG
    Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy
    European Urology; 49(6):1075-1078, 2006 (IF 6,512)
  • Ruszat R, Wyler S, Seifert HH, Reich O, Forster T, Stief  CG, Sulser T, Bachmann A
    Photoselective vaporization of the prostate: Experience with prostate adenomas >80 ccm
    Urologe A; 45(7): 858-864, 2006 (IF 0,391)
  • Ruszat R, Wyler S, Seifert H, Reich O, Forster T, Leippold T, Sulser T, Bachmann A
    Photoselective vaporization of the prostate: Subgroup analysis of men with refractory urinary retention
    European Urology; 50(5): 1040-1049, 2006 (IF 6,512)
  • Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A
    Safety and Effectiveness of Photoselective Vaporization of the Prostate (PVP) in Patients on Ongoing Oral Anticoagulation
    European Urology; 51(4): 1031-1038, 2007 (IF 6,512)
  • Gratzke C, Ückert S, Kedia G, Reich O, Schlenker B, Seitz M, Stief CG 
    In vitro effects of PDE-5 inhibitors sildenafil, vardenafil and tadalafil on isolated     human ureteral smooth muscle: a basic research approach
    Urological Research; 35(1): 49-54, 2007 (IF 1,615)
  • Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek PH, Lack N, Stief CG, Reich O Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study
    Journal of Urology; 177(4): 1419-1422, 2007 (IF 3,952)
  • Bader M, Hecht V, Hocaoglu Y, Staehler M, Reich O, Stief C, Sroka R
    Technical aspects of intraoperative assessment of treatment progress in laser lithotripsy
    Urologe A; 46(9): 1019-1026, 2007 (IF 0,391)
  • Gratzke C, Ückert S, Reich O, Schlenker B, Tilki D, Seitz M, Stief CG 
    PDE5 inhibitors: A new option in the treatment of ureteral colic ?
    Urologe A; 46(9): 1219-1223, 2007 (IF 0,391)
  • Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, Tilki D, Bachmann A, Stief CG, Reich O 
    The Diode laser: A novel side-fire approach for laser vaporisation of the human prostate – Immediate efficacy and 1-year follow-up
    European Urology; 52(6): 1717-1722, 2007 (IF 6,512)
  • Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R
    Diode laser: Ex-vivo studies on vaporization and coagulation characteristics
    Urologe A; 46(9): 1242-1247, 2007 (IF 0,391)
  • Bader MJ, Hecht V, Hocaoglu Y, Tilki D, Staehler M, Wondrazek F, Reich O, Stief CG, Sroka R
    In-vitro comparison of laser-induced lithotripsy on artificial stones by means of different laser systems
    Medical Laser Application; 22(4): 220-26, 2008
  • Sroka R, Ackermann A, Tilki D, Reich O, Steinbrecher V, Hofstetter A, Stief CG, Seitz M
    In-vitro comparison of the tissue vaporisation capabilities of different lasers. Medical Laser Application; 22(4): 227-31, 2008
  • Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knüchel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief C 
    Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid – First clinical experiences
    Urology; 72(2): 345-348,2008 (IF 2,242)
  • Ruszat R, Seitz M, Wyler SF, Abe C, Riecken M, Reich O, Gasser TC, Bachmann A
    Greenlight Laservaporization of the Prostate: Single-center experience and log-term results after 500 procedures
    European Urology; 54(4): 893-901, 2008 (IF 6,512)
  • Tilki D, Kilic N, Herbst H, Reich O, Seitz M, Lauke H, Stief C, Ergün S
    High level of endostatin in epididymal epithelium: Protection against primary malignancies in this organ ?
    Histochem Cell Biol; 130(3): 527-535, 2008 (IF 2,320)
  • Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek PH, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance    
    Morbidity, mortality and early outcome of transurethral resection of the prostate: A multicenter evaluation of 10654 patients
    Journal of Urology; 180(1): 246-249, 2008 (IF 3,952)
  • Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Riecken M, Reich O, Gasser TC, Bachmann A
    Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study
    British Journal of Urology International; 102(10):1432-1438, 2008 (IF 2,704)
  • Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, Sroka R, Reich O
    Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
    Laser Med Sci; 24(3):419-24, 2009 (IF 1,675)
  • Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P
    DNA integrity in plasma and serum of patients with malignant and benign diseases
    Ann NY Acad Sci; 1137:162-170, 2008 (IF 2,303)
  • Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M, Khoder W, Fischer F, Stief C, Sroka R 
    High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex-vivo investigations on porcine kidneys and human cadaver prostates
    Laser Med Sci; 24(2): 172-178, 2009 (IF 1,675)
  • Seitz M, Bayer T, Ruszat R, Tilki D, Bachmann A, Gratzke C, Schlenker B, Stief C, Sroka R, Reich O 
    Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations 
    British Journal of Urology International; 103(6):770-775, 2009 (IF 2,704)
  • Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, Bader M, Tilki D, Roosen A, Karl A, Reich O, Khoder W, Wyler S, Stief CG, Staehler M, Bachmann A
    Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma
    British Journal of Urology International; 104(4):470-5, 2009 (IF 2,704)
  • Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, Gasser TC, Reich O, Bachmann A
    Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
    British Journal of Urology International; 104(6):820-5, 2009 (IF 2,704)
  • Seitz M, Liedl B, Becker A, Gratzke C, Reich O, Stief C
    Upper transverse scrotal approach for muscle- and nerve-sparing urethral stricture repair
    World J Urol; 27(5):667-72 (IF 2,699)
  • Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knuechel R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief C
    Photodynamic Diagnosis Using 5-Aminolevulinic Acid for the Detection of Positive Surgical Margins during Radical Prostatectomy in Patients with Carcinoma of the Prostate: A Multicentre, Prospective, Phase 2 Trial of a Diagnostic Procedure 
    European Urology; 55(6):1281-8, 2009 (IF 6,512)
  • Reich O, Schlenker B, Gratzke C, Tilki D, Riecken M, Stief C, Seitz M, Bachmann A
    Plasma-Vaporisation of the prostate: Initial clinical results
    European Urology; 2009 May 26. [Epub ahead of print] (IF 6,512)
  • Tilki D, Singer BB, Shariat SF, Behrend A, Fernando M, Irmak S, Buchner A, Hooper AT, Stief CG, Reich O, Ergün S
    CEACAM1 - a novel urinary marker for bladder cancer detection 
    European Urology; 2009 May 28. [Epub ahead of print] (IF 6,512)
  • Seitz M, Gratzke C, Schlenker B, Buchner A, Karl A, Roosen A,  Singer B, Bastian P, Ergün S, Stief C, Reich O, Tilki D
    Contrast-Enhanced Transrectal Ultrasound (CE-TRUS) with Cadence-Contrast Pulse Sequence (CPS) Technology for the Detection of Prostate Cancer
    Urol Oncol; 2009 June 11. [Epub ahead of print] (IF 2,662)
  • Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P
    Transient Receptor Potential A1 and Cannabinoid Receptor Activity in Human Normal and Hyperplastic Prostate: Relation to Nerves and Interstitial Cells
    European Urology; 2009 Aug 28. [Epub ahead of print] (IF 6,512)
  • Tilki D, Zaak D, Trottmann M, Buchner A, Ekiz Y, Gerwens N, Schlenker B, Karl A, Walther S, Bastian PJ, Gratzke C, Tritschler S, Knüchel-Clarke R, Ergün S, Stief CG, Reich O*, Seitz M* 
    *Shared senior authorship
    Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
    World J Urol; 2009 Oct 22. [Epub ahead of print] (IF 2,699)
  • Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY,  Ergün S, Tewari AK, Stief CG, Seitz M, Reich O
    Clinical and pathological predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series
    Urol Oncol; 2009 Oct 16. [Epub ahead of print] (IF: 2,662)
  • Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche H, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
    Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients 
    Journal of Urology; 183(1): 87-93, 2010 (IF 3,952)
  • Schlenker B, Tilki D, Gratzke C, Seitz M, Reich O, Schneede P, Stief CG, Hungerhuber E
    Intermediate-differentiated invasive (pT1 G2) penile cancer - oncological outcome and follow-up 
    Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)
  • Schlenker B, Gratzke C, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Tilki D
    Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow up.
    Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)
  • Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, Tilki D, Reich O, Schneede P, Bartenstein P, Stief CG, Seitz M 
    Detection of Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma by 18F-Fluorodeoxyglucose PET/CT: A prospective single-center study
    Urol Oncol; 2009 Dec 16. [Epub ahead of print] (IF 2,662)
  • Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C
    Organ-preserving Nd:YAG laser therapy for penile carcinoma: long-term follow up
    British Journal of Urology International; 2010 Jan 19. [Epub ahead of print] (IF: 2,704)
  • Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C
    Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
    Eur J Med Res; in press 2009 (IF: 1,040)
  • Schlenker B, Gratzke C, Seitz M, von Walter P, Tilki D, Reich O, Zaak D, Stief CG, Bader MJ
    Minimizing complications during retropubic radical prostatectomy – is ureteral stenting necessary?
    Eur J Med Res; in press 2009 (IF: 1,040)
  • Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche H, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF 
    Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients 
    Journal of Urology; in press 2009 (IF 3,952)
  • Bader MJ, Gratzke C, Walther S, Weidlich P, Staehler M, Seitz M, Sroka R, Reich O, Stief CG, Schlenker B
    Efficacy of retrograde ureteropyeloscopic holmium laser lithotripsy for intrarenal calculi >2 cm
    Urological Research; 2010 Mar 4. [Epub ahead of print] (IF: 1,615)
  • Tilki D*, Reich O*, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF
    *Shared first authorship
    Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome
    European Urology; 2010 Jan 20. [Epub ahead of print] (IF: 6,512)
  • Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Vincenzo Ficarra, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF
    pT3 substaging is a prognostic indicator in lymph node negative urothelial carcinoma of the bladder
    Journal of Urology; in press 2010. (IF: 3,952)
  • Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O*, Shariat SF*
    *Shared senior authorship
    Stage pT0 at radical cystectomy confers an improvement in survival: An international study of 4430 patients
    Journal of Urology; in press 2010. (IF: 3,952)

Wissenschaftliche Arbeiten, Publikationen

Stand: März 2010

Meine wissenschaftlichen Publikationen dokumentieren die jahrzehntelange klinisch orientierte Forschungstätigkeit. Der Fokus liegt hierbei auf den Gebieten Benigne Prostatahyperplasie (BPH), Prostatakarzinom, Harnblasenkarzinom, Nierenzellkarzinom, Andrologie, Qualitätssicherung (outcome research) und chirurgische Simulation.

Die wissenschaftlichen Publikationen wurden begleitet von ca. 200 Vorträgen auf regionaler, nationaler und internationaler Ebene.

Aufgrund der unmittelbaren Relevanz für Patienten, fanden eine Vielzahl dieser Aktivitäten Niederschlag in regionalen und überregionalen Medien.

Impact-Factor der Orginalarbeiten (ohne Reviews)

Kumuliert: 209,459

Zitationen der Orginalarbeiten (ohne Reviews)

Kumuliert: 701

h-index 15 (www.ISI web of knowledge.com 10.03.2010)

Vorgestellt: Medizin, Mitarbeiter und Kontaktmöglichkeiten unserer Klinik